Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)

BACKGROUND: The observational MCL-004 study evaluated outcomes in patients with relapsed/refractory mantle cell lymphoma who received lenalidomide-based therapy after ibrutinib failure or intolerance. METHODS: The primary endpoint was investigator-assessed overall response rate based on the 2007 Int...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Wang, Michael, Schuster, Stephen J., Phillips, Tycel, Lossos, Izidore S., Goy, Andre, Rule, Simon, Hamadani, Mehdi, Ghosh, Nilanjan, Reeder, Craig B., Barnett, Evelyn, Bravo, Marie-Laure Casadebaig, Martin, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668956/
https://ncbi.nlm.nih.gov/pubmed/29096668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0537-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados